Similar articles

• Suppression of telomerase, reexpression of KAI1, and abrogation of tumorigenicity by nerve growth factor in prostate cancer cell lines.

  Sigala S, Faraoni I, Botticini D, Paez-Pereda M, Missale C, Bonmassar E, Spano P. Sigala S, et al. Clin Cancer Res. 1999 May;5(5):1211-8. Clin Cancer Res. 1999. PMID: 10353759
• Prevention of metastasis by inhibition of the urokinase receptor.

  Crowley CW, Cohen RL, Lucas BK, Liu G, Shuman MA, Levinson AD. Crowley CW, et al. Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5021-5. doi: 10.1073/pnas.90.11.5021. Proc Natl Acad Sci U S A. 1993. PMID: 8389464 Free PMC article.
• Metastasis induced by overexpression of p185neu-T after orthotopic injection into a prostatic epithelial cell line (NbE).

  Marengo SR, Sikes RA, Anezinis P, Chang SM, Chung LW. Marengo SR, et al. Mol Carcinog. 1997 Jul;19(3):165-75. Mol Carcinog. 1997. PMID: 9254883
• [Role of a transforming growth factor beta-1 in regulation of invasive growth of prostatic adenocarcinoma].

  Gladskikh OP, Danilova TI, Kuznetsova AB, Ivanov AA, Andreeva IuIu, Alekseev BIa, Frank GA, Pal'tsev MA. Gladskikh OP, et al. Arkh Patol. 2004 May-Jun;66(3):27-30. Arkh Patol. 2004. PMID: 15318553 Review. Russian.
• The heterogeneous nature of metastatic neoplasms: implications for the treatment of cancer.

  Fidler IJ, Kozlowski JM. Fidler IJ, et al. Urology. 1984 Apr;23(4 Suppl):29-38. doi: 10.1016/s0090-4295(84)80064-3. Urology. 1984. PMID: 6369719 Review. No abstract available.